Yamada Shozo, Ohyama Kenichi, Taguchi Manabu, Takeshita Akira, Morita Koji, Takano Koji, Sano Toshiaki
Department of Hypothalamic and Pituitary Surgery, Endocrine Center, Toranomon Hospital, Tokyo, Japan.
Neurosurgery. 2007 Sep;61(3):580-4; discussion 584-5. doi: 10.1227/01.NEU.0000290906.53685.79.
The aims of this study are to review the histology of the clinically nonfunctioning pituitary adenomas (CNFPAs) we have observed and to determine whether or not the frequency of cavernous sinus invasion is different among each type of morphology.
In addition, several proliferative markers, including Ki67, p53, E-cadherin, matrix metallo-proteinase 9 and pituitary tumor derived fibroblast growth factor receptor 4 (ptd-FGFR4), were also investigated in invasive and non-invasive tumors.
Our consequent 213 CNFPAs were diagnosed as follows: 64% were silent gonadotroph adenomas, 18% were null cell adenomas, 12% were silent corticotroph adenomas, 4% were silent Subtype 3 adenomas, and 1% were other types of adenomas. Female patients or younger patients showed a significant preponderance in silent corticotroph adenomas and in silent Subtype 3 adenomas, respectively. Cavernous sinus invasion occurs most frequently in silent corticotroph adenomas (85%) followed by Subtype 3 adenomas (67%), null cell adenomas (38%), and silent gonadotroph adenomas (11%). There were no significant differences in the Ki67, p53, E-cadherin, matrix metallo-proteinase 9, and ptd-FGFR4 expression between tumors with and without cavernous sinus invasion.
From a clinical standpoint, it is quite important to differentiate morphological type in CNFPAs to aid the clinician in assessing the clinical behavior and prognosis of the tumor. Therefore, we suggest that all CNFPAs be examined not only by conventional light microscopy but also by immunohistochemistry, preferably by electron microscopy, to achieve a correct morphological diagnosis.
本研究旨在回顾我们所观察到的临床无功能垂体腺瘤(CNFPAs)的组织学特征,并确定每种形态类型的海绵窦侵犯频率是否存在差异。
此外,还对侵袭性和非侵袭性肿瘤中的几种增殖标志物进行了研究,包括Ki67、p53、E-钙黏蛋白、基质金属蛋白酶9和垂体肿瘤衍生的成纤维细胞生长因子受体4(ptd-FGFR4)。
我们随后诊断的213例CNFPAs如下:64%为无功能促性腺激素腺瘤,18%为空细胞腺瘤,12%为无功能促肾上腺皮质激素腺瘤,4%为无功能3型腺瘤,1%为其他类型腺瘤。女性患者或年轻患者分别在无功能促肾上腺皮质激素腺瘤和无功能3型腺瘤中显著居多。海绵窦侵犯最常发生在无功能促肾上腺皮质激素腺瘤(85%),其次是3型腺瘤(67%)、空细胞腺瘤(38%)和无功能促性腺激素腺瘤(11%)。在有和没有海绵窦侵犯的肿瘤之间,Ki67、p53、E-钙黏蛋白、基质金属蛋白酶9和ptd-FGFR4表达没有显著差异。
从临床角度来看,区分CNFPAs的形态类型对于帮助临床医生评估肿瘤的临床行为和预后非常重要。因此,我们建议对所有CNFPAs不仅要通过传统光学显微镜检查,还要通过免疫组织化学检查,最好通过电子显微镜检查,以实现正确的形态学诊断。